STAT

MAY 14, 2024

At the time, the Food and Drug Administration required Amgen to run a trial confirming earlier test results, as well as a so-called post-marketing study to examine safety and effectiveness at different dosages, in order to gain full approval. Continue to STAT+ to read the full story…

Dosage 351

Dosage 351

Express Pharma

JANUARY 17, 2025

As environmental concerns continue to intensify, the pressure on the pharmaceutical industry to reduce its overall environmental impact, particularly in final dosage forms, is growing proportionately. In March 2024, Lonza hosted its first digital Responsible Supplier Event which brought together more than 1,100 participants.

Dosage 104

Dosage Pharmaceutical Manufacturing Packaging Drug Development 104

European Pharmaceutical Review

MARCH 9, 2023

Based on the latest report and data, HPAPI market size is expected to reach $32 billion by 2028. With a career spanning over 20 years, Dr Hotha has extensive expertise in developing drug substances and products, particularly in HPAPI, Drug linkers, ADCs, and complex drug dosage forms.

Compounding 98

Compounding Dosage Communication 98

European Pharmaceutical Review

OCTOBER 12, 2023

Subject to planning permission, the site is expected to be opened by 2028. A €25 million drug delivery manufacturing investment To boost capacity in producing user-friendly oral dosage forms, German CDMO HERMES Pharma announced in September it is investing €25 million in its manufacturing capabilities.

Pharmaceutical Manufacturing 104

Pharmaceutical Manufacturing Vaccines Dosage Pharmaceutical Companies 104

Pharmaceutical Technology

AUGUST 22, 2022

According to the World Health Organisation, the simplicity of a dosage regimen is one of the factors with the greatest influence on therapy adherence[1]. The softgel capsule can contain a second solid dosage form, in softgel, tablet or granule form, enabling multi-active formulations for unique prescription, OTC and nutraceutical products.

Dosage 52

Dosage 52

Pharmaceutical Technology

FEBRUARY 13, 2023

This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active. GlobalData’s analyst consensus forecast database estimates peak annual sales for ARV-110 of $325 million in 2028.

Dosage 59

Dosage Chemotherapy Compounding Immunity 59